Growth Metrics

Verastem (VSTM) Cash & Current Investments (2011 - 2026)

Verastem's quarterly Cash & Current Investments came in at $181.7 million in Q1 2026, up 54.53% year-on-year from $117.6 million in Q1 2025, and down 11.37% quarter-over-quarter from $205.0 million in Q4 2025.

Verastem has reported Cash & Current Investments for 16 years, with the latest figure at $181.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments rose 54.53% year-over-year to $181.7 million; the trailing twelve-month figure through Mar 2026 stood at $181.7 million (up 54.53% YoY), and the FY2025 full-year result was $205.0 million, up 130.8% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $181.7 million, down from $205.0 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $205.0 million in Q4 2025, with the low at $83.4 million in Q2 2024.
  • Average Cash & Current Investments over 5 years is $129.1 million, with a median of $113.2 million recorded in 2024.
  • Year-over-year, Cash & Current Investments slumped 54.46% in 2024 and jumped 130.8% in 2025.
  • Tracing VSTM's Cash & Current Investments over 5 years: stood at $92.0 million in 2022, then jumped by 48.99% to $137.1 million in 2023, then sank by 35.23% to $88.8 million in 2024, then jumped by 130.8% to $205.0 million in 2025, then retreated by 11.37% to $181.7 million in 2026.
  • The last three Cash & Current Investments figures came in at $181.7 million (Q1 2026), $205.0 million (Q4 2025), and $137.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 2.13 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 32.30 Mn
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 61.46 Mn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 7.25 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 8.75 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 3.01 Bn
10 Verastem 425.60 Mn 243.93 Mn 15.90 Mn 181.68 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 181.68 Mn
Dec 31, 2025 204.99 Mn
Sep 30, 2025 137.71 Mn
Jun 30, 2025 164.32 Mn
Mar 31, 2025 117.57 Mn
Dec 31, 2024 88.82 Mn
Sep 30, 2024 113.18 Mn
Jun 30, 2024 83.37 Mn
Mar 31, 2024 110.13 Mn
Dec 31, 2023 137.13 Mn
Sep 30, 2023 165.66 Mn
Jun 30, 2023 183.09 Mn
Mar 31, 2023 111.20 Mn
Dec 31, 2022 92.04 Mn
Sep 30, 2022 103.98 Mn
Jun 30, 2022 94.31 Mn
Mar 31, 2022 106.28 Mn
Dec 31, 2021 153.80 Mn
Sep 30, 2021 103.42 Mn
Jun 30, 2021 108.14 Mn
Mar 31, 2021 121.10 Mn
Dec 31, 2020 141.23 Mn
Sep 30, 2020 170.47 Mn
Jun 30, 2020 4.89 Mn
Mar 31, 2020 135.06 Mn
Dec 31, 2019 75.51 Mn
Sep 30, 2019 160.23 Mn
Jun 30, 2019 187.25 Mn
Mar 31, 2019 211.66 Mn
Dec 31, 2018 249.65 Mn
Sep 30, 2018 145.64 Mn
Jun 30, 2018 168.69 Mn
Mar 31, 2018 64.22 Mn
Dec 31, 2017 86.67 Mn
Sep 30, 2017 60.26 Mn
Jun 30, 2017 57.92 Mn
Mar 31, 2017 72.57 Mn
Dec 31, 2016 80.90 Mn
Sep 30, 2016 86.88 Mn
Jun 30, 2016 92.87 Mn
Mar 31, 2016 99.54 Mn
Dec 31, 2015 110.26 Mn
Sep 30, 2015 120.47 Mn
Jun 30, 2015 132.09 Mn
Mar 31, 2015 132.07 Mn
Dec 31, 2014 92.68 Mn
Sep 30, 2014 93.37 Mn
Jun 30, 2014 98.60 Mn
Mar 31, 2014 105.64 Mn
Dec 31, 2013 101.31 Mn
Sep 30, 2013 99.93 Mn
Jun 30, 2013 57.45 Mn
Mar 31, 2013 66.72 Mn
Dec 31, 2012 56.58 Mn
Sep 30, 2012 46.85 Mn
Jun 30, 2012 38.69 Mn
Mar 31, 2012 41.07 Mn
Dec 31, 2011 60.76 Mn
Sep 30, 2011 41.42 Mn
Jun 30, 2011 14.16 Mn
Mar 31, 2011 2.72 Mn